News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘LungCancer’ clear

  • By mapping the interlocking structures of small molecules and mutated protein "receptors" in non-small cell lung cancer (NSCLC) cells, scientists at Dana-Farber and their colleagues have energized efforts to design molecules that mesh with these receptors, potentially interfering with cancer cell growth and survival.

Tags: LungCancer

  • An international research team, led by investigators from the Massachusetts General Hospital (MGH) Cancer Center and Dana-Farber Cancer Institute, has found a new way that some lung tumors become resistant to treatment with targeted therapy drugs like Iressa and Tarceva.

Tags: LungCancer

  • A widely used diabetes drug dramatically boosted the potency of platinum-based cancer drugs when administered together to a variety of cancer cell lines and to mice with tumors, scientists from Dana-Farber report.

Tags: LungCancer, OvarianCancer

  • Blacks in the United States are less certain than whites about recommendations to prevent lung cancer and are more fearful of having symptoms evaluated — beliefs that may keep them from seeking timely treatment for the disease, researchers from Dana-Farber Cancer Institute reported at the American Society of Clinical Oncology's annual meeting in Chicago.

Tags: LungCancer, Disparities

  • Collaborating scientists in Boston and North Carolina have found that a particular gene can block key steps of the lung cancer process in mice. The researchers report in the journal Nature that LKB1 is not only a "tumor-suppressor" gene for non-small cell lung cancer in mice, it also may be more powerful than other, better-known suppressors.

Tags: BasicResearch, LungCancer

  • A collaborative study involving Dana-Farber researchers has unearthed a variety of genetic alterations in lung tumors, more than doubling the number already linked to the disease.

Tags: Genomics, LungCancer

  • Researchers at Boston cancer centers have found that a combination of kinase inhibitors may lead to future treatments for lung cancer, colon cancer, and prostate tumors.

Tags: KinaseInhibitor, LungCancer

  • Researchers have halted non-small cell lung tumors resistant to Iressa and Tarceva with a newly constructed compound that may also have fewer side effects.

Tags: DrugResistance, LungCancer

  • Identifying patients with a specific gene mutation that enables drug resistance, and treating them with a combination of drugs, may produce longer remissions, say researchers.

Tags: EGFR, LungCancer

  • The study found African Americans are more likely to hold perceptions that could interfere with prevention and treatment and indicate a need for improved public health communication about lung cancer.

Tags: BasicResearch, LungCancer

Showing 1-10 of 26 items